CytomX Therapeutics, Inc. (FRA:6C1)

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $5.96M USD in the quarter ending September 30, 2025, a decrease of -82.16%. This brings the company's revenue in the last twelve months to $113.63M, down -10.26% year-over-year. In the year 2024, CytomX Therapeutics had annual revenue of $138.10M with 36.45% growth.

• Revenue (ttm): $113.63M
• Revenue Growth: -10.26%
• P/S Ratio: 5.94
• Revenue / Employee: $939.10K
• Employees: 121
• Market Cap: 575.30M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.10M	36.89M	36.45%
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%